The thymosins--preclinical and clinical studies with fraction V and alpha-I.
D000954:Antigens, Surface / Q000032:analysis; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D007700:Kinetics; D007958:Leukocyte Count; D008175:Lung Neoplasms / Q000188:drug therapy; D007959:Lymphocyte Culture Test, Mixed; D009369:Neoplasms / Q000188:drug therapy*; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D000077596:Thymalfasin; D013947:Thymosin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000954:Antigens, Surface; C033782:thymosin fraction 5; D013947:Thymosin; D000077596:Thymalfasin